Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies

Neuropathology

Volumn 31, Issue 1, 2011, Pages 1-10

  Bernstein, Hans Gert ^a   Johnson, Mary ^b   Perry, Robert H ^c   LeBeau, Fiona E N ^d   Dobrowolny, Henrik ^a   Bogerts, Bernhard ^a   Perry, Elaine K ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alpha synuclein; Dementia with Lewy bodies; Hippocampus; Interneurons; Morphometry; Parvalbumin

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM BINDING PROTEIN; PARVALBUMIN;

AGED; ANTIBODY LABELING; ARTICLE; CELL DENSITY; CELL FUNCTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DENTATE HILUS; DIFFUSE LEWY BODY DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; QUANTITATIVE ANALYSIS;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CELL COUNT; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INTERNEURONS; LEWY BODY DISEASE; MALE; PARVALBUMINS;

EID: 78751474339     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01117.x     Document Type: Article

References (52)

1. Andersson M, Hansson O, Minthon L, Rosen I, Londos E. Electroencephalogram variability in dementia with Lewy bodies, Alzheimer's disease and controls. Dement Geriatr Cogn Disord 2008; 26: 284-290.
2. Briel RCG, McKeith IG, Barker WA et al. EEE findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 66: 401-403.
3. McKeith IG, Perry EK, Perrry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999; 53: 902-905.
4. McKeith IG, Dickson DW, Lowe J et al. Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
5. Neumann M, Müller V, Kretzschmar HA, Haass C, Kahle PJ. Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage. J Neuropathol Exp Neurol 2004; 63: 1125-1235.
6. Yokota O, Tsuchiya K, Uchihara T et al. Lewy body variant of Alzheimer's disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem. Neuropathology 2007; 27: 21-35.
7. Barber R, Ballard C, Mckeith IG et al. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000; 28: 1304-1309.
8. Barber R, McKeith IG, Ballard C et al. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord 2001; 12: 198-205.
9. Firbank MJK, Teodorczuk MS, English A et al. Atrophy is associated with posterior cingulate and white matter disruption in dementia with Lewy bodies and Alzheimer's disease. Neuroimage 2007; 36: 1-7.
10. Sabattoli F, Boccardi M, Galluzzi S et al. Hippocampal shape differences in dementia with Lewy bodies. Neuroimage 2008; 41: 699-705.
11. Revuelta GJ, Rosso A, Lippa CF. Neuritic pathology as a correlate of synaptic loss in dementia with Lewy bodies. Am J Alzheimers Dis Other Demen 2008; 23: 97-102.
12. Harding AJ, Lakay B, Halliday GM. Selective hippocampal neuron loss in dementia with Lewy bodies. Ann Neurol 2002; 51: 125-128.
13. Uchikado H, Iseki E, Tsuchiya K et al. Dementia with Lewy pathology but minimal Alzheimer pathology - Lewy pathology causes neuronal loss inducing progressive dementia. Clin Neuropathol 2002; 21: 269-277.
14. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994; 35: 81-88.
15. Gomez-Tortosa E, Sanders JL, Newell K et al. Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies. Acta Neuropathol 2001; 101: 36-42.
16. Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti ubiquitin and SMI32. Acta Neuropathol 1995; 89: 404-408.
17. Gureviciene I, Gureviciene K, Tanila H. Aging and alpha-synuclein affect synaptic plasticity in the dentate gyrus. J Neural Transm 2009; 116: 13-22.
18. Abdi F, Quinn JF, Jankovic J et al. Detection of biomarkers with the multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 2006; 9: 293-348.
19. Zhang J. Biomarkers for neurodegenerative disorders. U.S. Patent 20090131265. 2009.
20. Braak E, Strotkamp D, Braak H. Parvalbumin immunoreactive structures in the hippocampus of the human adult. Cell Tissue Res 1991; 264: 33-48.
21. Seress L, Gulyás AI, Ferrer I et al. Distribution, morphological features, and synaptic connections of parvalbumin-and calbindin D28k-immunoreactive neurons in the human hippocampal formation. J Comp Neurol 1993; 33: 208-230.
22. Ribak CE, Nitsch R, Seress L. Proportion of parvalbumin-positive basket cells in the GABAergic innervation of pyramidal and granular cells of the rat hippocampal Formation. J Comp Neurol 1990; 300: 449-461.
23. Fuchs EC, Zivkovic AR, Cunningham MO. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behaviour. Neuron 2007; 53: 591-604.
24. Herrmann CS, Demiralp T. Human EEG gamma oscillations in neuropsychiatric disorders. Clin Neurophysiol 2005; 116: 2719-2733.
25. Bernstein H-G, Stanarius A, Baumann B et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867-875.
26. Betts-Henderson J, Jaros E, Krishnan KJ. Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions. Neuropathol Appl Neurobiol 2009; 35: 120-124.
27. Bernstein H-G, Bukowska A, Krell D. Comparative localization of ADAMs 10 and 15 in human cerebral cortex:normal aging, Alzheimer disease and Down syndrome. J Neurocytol 2003; 32: 153-160.
28. Bernstein H-G, Krause S, Krell D. Strongly reduced number of parvalbumin-immunoreactive projection neurons in the mammillary bodies in schizophrenia: further evidence for limbic neuropathology. Ann N Y Acad Sci 2007; 1096: 120-127.
29. Braak H, Braak E. Neuropathological stageing of Alzheimer related changes. Acta Neuropathol 1991; 82: 239-259.
30. Perry G, Richey P, Siedlack SL, Galloway P, Kawai M, Cras P. Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases. Brain Res 1992; 579: 350-392.
31. Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus of schizophrenia. Schizophr Res 2002; 55: 1-10.
32. Small SA. Measuring correlates of brain metabolism with high-resolution MRI: a promising approach for diagnosing Alzheimer disease and mapping its course. Alzheimer Dis Assoc Disord 2003; 17: 154-161.
33. Shults CW. Lewy bodies. Proc Natl Acad Sci USA 2006; 103: 1661-1668.
34. Jellinger KA. Lewy body/alpha synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol 2009; 117: 423-427.
35. Jellinger KA. Formation and development of Lewy pathology: a critical update. J Neurol 2009; 256 (Suppl 3): 270-279.
36. Chan-Palay VC, Zetzsche T, Höchli M. Parvalbumin neurons in the hippocampus in senile dementia of the Alzheimer type, Parkinson's disease and multi-infarct dementia. Dement Geriatr Cogn Disord 1991; 2: 297-313.
37. Brady DR, Mufson EJ. Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain. Neuroscience 1997; 80: 1113-1125.
38. Hof PR, Cox K, Young WG et al. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 1991; 50: 452-462.
39. Ferrer I, Soriano E, Tunon T et al. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J Neurol Sci 1991; 106: 135-141.
40. Leuba G, Kraftsik R, Saint K. Quantitative distribution of parvalbumin, calretinin, and calbindin D-28K immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Exp Neurol 1998; 152: 278-291.
41. Thangavel R, Van Hoesen GW, Zaheer A. Posterior parahippocampal gyrus pathology in Alzheimer's disease. Neuroscience 2008; 23: 667-676.
42. Lisman JE, Coyle JT, Green RW et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008; 31: 234-242.
43. Beyer K, Domingo-Sabàt M, Ariza A. Molecular pathology of Lewy body disease. Int J Mol Sci 2009; 10: 724-745.
44. Gorman AM. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med 2008; 12: 2263-2280.
45. Rosenstein JM, More NS, Mani N et al. Developmental expression of calcium-binding protein-containing neurons in neocortical transplants. Cell Transplant 1998; 7: 121-129.
46. Soos J, Engelhardt JI, Siklos L et al. The expression of PARP, NF kappa B and parvalbumin is increased in Parkinson disease. Neuroreport 2004; 15: 1715-1718.
47. Ramonet D, de Yebra L, Fredriksson K et al. Similar calcification process in acute and chronic human brain pathologies. J Neurosci Res 2006; 83: 147-156.
48. Maetzler W, Stünitz H, Bendfeldt K et al. Microcalcification after excitotoxicity is enhanced in transgenic mice expressing parvalbumin in all neurones, may commence in neuronal mitochondria and undergoes structural modifications over time. Neuropathol Appl Neurobiol 2009; 35: 165-177.
49. Atoji Y, Yamamoto Y, Suzuki Y. Parvalbumin in cortical epithelial cells of the pigeon thymus. J Anat 2000; 196: 305-311.
50. Uhlhaas PJ, Linden DE, Singer W et al. Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia. J Neurosci 2006; 26: 8168-8175.
51. Ribary U, Ioannides AA, Singh KD et al. Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans. Proc Natl Acad Sci USA 1991; 88: 11037-11041.
52. Bonanni L, Thomas A, Tiraboshi P et al. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia with 2- year follow-up. Brain 2008; 131: 690-715.